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Abstract 
Incidence of Contras incident Induced Nephropathy (CIN) after percutaneous coronary intervention (PCI) is a 
determinant factor of Acute Kidney Injury (AKI). Risk factors evidence can strengthen the prevention of CIN 
before PCI intervention performed. This study aimed to identify risk factors for the incidence of CIN in 
Coronary Artery Disease (CAD) patients obtained PCI. Evidence of the risk factors can strengthen the 
prevention of CIN before PCI intervention performed. This study aimed to identify risk factors for the incidence 
of CIN in patients with CAD obtained PCI.  
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It was a quantitative research with retrospective design, population were coronary artery disease (CAD) patients 
and sample size were 25 patients. Bivariate analysis using Fisher exact statitistical test showed that variable 
associated significantly with the incidence of CIN only diabetes mellitus (OR = 21.000, P = 0.007, 95% CI = 
1922-299392)  while the variable gender, age, smoking, acute myocardial infarction and hypertension did not 
have a significant relationship (p> 0.05). Predictor for incindence CIN based on binary regression analysis was 
diabetes mellitus (PR = 21.000, P = 0.007, 95% CI = 1922-299392) while  variable gender, age, smoking, acute 
myocardial infarction and hypertension did not have a significant relationship (p> 0.05). Result of this study 
reinforces the need prevention for patients with risk factors before PCI intervention especially diabetes mellitus. 
Keywords: Contras Induced Nephrophaty; Percutaneous Coronary Intervention; Diabetes Mellitus. 
1. Introduction  
Administration of contrast agents in coronary artery disease patients when percutaneous coronary intervention 
(PCI) is a risk factor for the occurrence of contrast induced nephrophaty (CIN),  patient characteristics such as 
age and history of disease is also risk factor for the occurrence of CIN [1-3]. Incidence of CIN may develop to 
acute kidney injury and was significantly associated with morbidity of hospitalized patients [4].  
Some studies revealed that CIN incidence in women increased morbidity and mortality. Age, gender and 
incidence of diabetes mellitus are predictor of the incidence of CIN after PCI [5-7]. The aging and 
cardiovascular disease itself is also a determinant of CIN [8]. Diabetes mellitus is a predisposing factor for CIN 
via several mechanisms such as an increase in the tubules transport activity and formation of reactive oxygen 
species [9]. Increased Risk of CIN and bad prognostic in patients with diabetes mellitus type 2 Become a 
consideration for preparing prevention before administration of contrast agents [10, 11]. 
Knowledge of risk factors can be useful for the prevention and treatment of CIN incidence. Provision of contrast 
media should be postponed in patients with congestive heart failure until haemodynamic status can be resolved 
and delayed 24 hours for patients with myocardial infarction. Important consideration also for patients who have 
risk factors to be considered in getting hypo-osmolar contrast media [12].  
Research about CIN in Makassar, South Sulawesi is infrequent, so this study aims to identify risk factors for the 
incidence of CIN in patients with cardiovascular obtained PCI in wahidinsudirohusodo hospital in Makassar, 
South Sulawesi. 
2. Material and  Methods 
This study was retrospective that investigated variables suspected could be a predictor for cardiovascular CIN in 
patients undergoing PCI at Wahidin Sudirohusodo hospital, Makassar, South Sulawesi. Risk factor variables  
was obtained from medical records of patients. The population were all  Coronory Artery Disease (CAD) 
patients which assigned PCI, sample size were 25 patients obtained by accidental sampling.  
Serum creatinine patients were examined  24-48 hours after PCI then categorized into two groups;  patients 
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experienced CIN and patients did not experience CIN. This criterion was based on  increasing of serum 
creatinine > 0.5 mg /dl or  25% improvement from baseline in 24-48 hours after PCI. It was according to Kidney 
Disease Improving Global Outcomes (KDIGO) of the year 2012. 
Using bivariate statistical analysis with Fisher Exact test followed by a multivariate analysis, binary logistic 
regression. Data then displayed with table contained  frequency and percent along with  odds ratio (OR) value, 
probability  value(p) and confidence interval (CI) of 95%, declared significant if the p value ≤0.05. 
3. Result 
Bivariate analysis showed variable associated  significantly with incidence of CIN only diabetes mellitus (PR = 
21.000, P = 0.007, 95% CI = 1922-299.392) while variables gender, age, smoking, acute myocardial infarction 
and hypertension did not have a significant relationship (p≥0.05) (Table 1). Variables  met the criteria (p <0.25), 
namely age, smoking habits and history of diabetes mellitus included in multivariate analysis (Table 2). 
Table 1: Risk of Cotrast Induced Nephrophaty 
 Incidence of Contras Induced 
Nephrophaty 
 
 
OR 
 
 
P 
 
 
95% CI Yes 
(n=10) 
No 
(n=15) 
n % n % 
Gender Female 1  4.00 1   4.00  
1.556 
 
0.650* 
 
0.086-28.145  Male 9 36.00 14 56.00 
         
Age (year) <60 5 20.00 13 52.00 6.500 0.075* 0.937-45.106 
 ≥60 5 20.00 2   8.00 
         
Smoking  Yes 3 12.00 2   8.00 0.359 0.248* 0.048-2.689 
 No 7 28.00 13 52.00 
         
Miocard Infarc Acute Yes 2 8.00 6 24.00   0.583 0.402* 0.058-2.414 
 No 8 52.00 9 32.00 
         
Congestive Heart 
Failure 
Yes 2 8.00 2 8.00 1.625 0.532* 0.190-13.933 
 No 8 32.00 13 52.00    
         
Diabetes Mellitus Yes 6 24.00 `1 4.00 21.000 0.007* 1.922-
229.392  No 4 16.00 14 56.00 
         
Hypertension Yes 8 32.00 12 48.00 1.000 0.687* 0.135-7.932 
 No 3   8.00 2 12.00 
         
* Fisher Exact Tesr  
n=number, OR=Odd Ratio,P=probability, CI=confidence interval 
Binary logistic regression analysis in table 2 showed that variable was being significant predictors  for incidence 
of CIN after  PCI was  history of diabetes mellitus (OR = 4.199, P = 0040.95% CI=1.125-202.026) while age 
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and smoking habits were not predictor of  CIN incidence (p> 0.05). 
Table 2: Multivariate Regression Analysis 
Variable OR P 95%CI 
Age 1.184 0.277 0.361-35.106 
Smoking 0.002 0.969 0.053-16.848 
Diabetes Mellitus 4.199 0.040a 1.125-202.026a 
 OR=Odd Ratio,P=probability, CI=confidence interval 
 asignificant (p≤0.05) 
4. Discussion 
Study results revealed that variables associated significantly and be a predictor for  incidence of CIN only  
diabetes mellitus disease. Patients who had insulin resistance and diabetes mellitus were more susceptible to 
CIN compared with non-diabetic patients both  PCI and non PCI, [13, 14]. Kidneys of diabetic patients are 
particularly vulnerable to hypoxia and oxidative stress after  administration of contrast agent, hypoxia induced 
formation of reactive oxygen species (ROS)  and it has an important role in the pathogenesis of CIN [9].  ROS 
could lead to injury of vascular endothelial tubules directly and as a trigger of renal parenchymal hypoxia 
induced  endothelial dysfunction and dysregulation of tubular transport [15]. Giving contras media (CM) 
increase  production of ROS and renal oxidative stress which mediates damage  cell membrane and induced 
apoptosis and necrosis [16]. Administration low or iso-osmolar contrast media, hydration pre- and post-contrast 
hydration with 1500 ml of 0.9% saline solution infusion (N-acetylcysteine (NAC) associated with sodium 
bicarbonate (Na2HCO3) infusion) could be alternative for patients with history of diabetes mellitus or renal 
dysfunction [17-21]. 
This study was consistent with the results of global finding that diabetes mellitus was predictor for inceidence of 
CIN. It provided recommendations for medical services, especially in Makassar, South Sulawesi, Indonesia that 
patients with a history of diabetes mellitus would need precaution before PCI. Further research should explore  
predictor variables for CIN with larger sample size and more variable in order to provide prevention 
recommendations for patients undergoing PCI. 
5. Conclusion 
History of diabetes mellitus was predictor variable for patients with coronary artery disease (CAD) undergoing 
PCI, it reinforces requirement for prevention in patients with risk factors before PCI intervention. 
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